Generic Contrast Agents – Visit Fresenius Kabi at Booth #3238, South Hall
Options that provide choice and value from the leading provider of generic contrast agents.
As the leading provider of generic contrast agents, Fresenius Kabi is committed to providing the radiology community with choice and value through cost-effective generic contrast agents.
For health care providers, having options can be an important consideration when planning for the needs of their patients. Fresenius Kabi brings its experience as a leading provider of generic injectable pharmaceuticals to the contrast agent market.
Fresenius Kabi has:
- Supplied over 4.5 million vials of contrast agents in the U.S. since launch.
- Supported over 2,100health care facilities across America.
- Invested in the market to support a reliable supply of generic contrast agents for health care providers and their patients.
These efforts reflect Fresenius Kabi’s commitment to being a reliable partner and providing cost-effective generic contrast agent options for health care facilities and their patients.
In today’s world, relying on a single source of supply can be challenging. Diversifying suppliers can help keep your options open and provide greater flexibility in sourcing contrast agents.
By partnering with Fresenius Kabi, you will have access to FDA-approved generic contrast agents that are fully substitutable to the brand-name products – at a lower cost.
Now you have a choice.
Explore available contrast agents exclusively from Fresenius Kabi at GenericContrastAgents.com.
Visit Fresenius Kabi at the RSNA 2026 Annual Meeting. Booth #3238, South Hall.
